Making the Cut | Session 2: Cardiovascular Disease and Sickle Cell Anemia

Tuesday, November 26, 2019

Making the Cut | Session 2: Cardiovascular Disease and Sickle Cell Anemia || Radcliffe Institute

The 2019 Radcliffe Institute science symposium is on gene editing, a technology that enables scientists to change an organism’s DNA. Leading international scientists, clinicians, and ethicists gather to explore case studies of particular gene therapies and consider the legal and bioethical implications of this research.

SESSION 2: CASE STUDIES: HEART DISEASE; SICKLE CELL ANEMIA
Introduction by moderator Omar Abudayyeh, fellow, McGovern Institute for Brain Research, MIT

(
7:39) Vence L. Bonham Jr., senior advisor to the director on genomics and health disparities, National Human Genome Research Institute

(
30:07) Kiran Musunuru, associate professor of medicine, Perelman School of Medicine, University of Pennsylvania

PANEL DISCUSSION (
54:26)
AUDIENCE Q&A (
1:08:51)